Healthcare · Medical - Devices
Price
$3.31
Market Cap
$1.5M
Employees
7
Beta
0.82
Avg Volume
1,318,643
CEO
Indranil Dey
Business Description
Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system. This platform is composed of the Symphony analyzer, which skillfully orchestrates the processing of whole blood, the isolation of biomarkers, and the preparation of immunoassays using non-contact centrifugal force. It also includes the Symphony Cartridge, which comes pre-loaded with essential reagents and components. The company additionally provides the ALLEREYE diagnostic test, a convenient, on-site device for quickly identifying allergic conjunctivitis. Bluejay Diagnostics is also progressing with the development of Symphony IL-6 tests, intended for monitoring disease advancement in critical care environments. Furthermore, they are actively creating additional diagnostic tests for their Symphony platform, such as those aimed at detecting myocardial infarction (heart attack) and congestive heart failure. Bluejay Diagnostics, Inc. was founded in 2015 and is headquartered in Acton, Massachusetts.
Business History
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-0.22
Stock Price: $3.31
EPS (Diluted): -15.25
EPS (Diluted): -15.25
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
0.20
Stock Price: $3.31
Total Equity: $5.98M
Shares: 449,043
Total Equity: $5.98M
Shares: 449,043
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
0.34
Market Cap: $1.50M
Total Debt: $0.00
Cash: $5.16M
EBITDA: -$6.68M
Total Debt: $0.00
Cash: $5.16M
EBITDA: -$6.68M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
-$3.8M
Market Cap: $1.50M
Total Debt: $0.00
Cash: $5.16M
Total Debt: $0.00
Cash: $5.16M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
0.00
Stock Price: $3.31
Revenue: $0.00
Shares: 449,043
Revenue: $0.00
Shares: 449,043
EV/Sales (Total value vs revenue — works when P/E can't)
API0.00
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
0.0%
Gross Profit: $0.00
Revenue: $0.00
Revenue: $0.00
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
0.0%
Operating Income: -$6.95M
Revenue: $0.00
Revenue: $0.00
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
0.0%
Net Income: -$6.85M
Revenue: $0.00
Revenue: $0.00
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-144.3%
Net Income: -$6.85M
Total Equity: $5.98M
Total Equity: $5.98M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-163.5%
Operating Income: -$6.95M
Tax Rate: 0.0%
Equity: $5.98M
Total Debt: $0.00
Cash: $5.16M
Tax Rate: 0.0%
Equity: $5.98M
Total Debt: $0.00
Cash: $5.16M
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
4.88
Current Assets: $5.46M
Current Liabilities: $1.12M
Current Liabilities: $1.12M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $5.98M
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $5.98M
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
Revenue / Shares Outstanding
—
Revenue: $0.00
Shares: 449,043
Shares: 449,043
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$13.31
Total Equity: $5.98M
Shares: 449,043
Shares: 449,043
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-13.87
Operating CF: -$6.05M
CapEx: -$173,735
Shares: 449,043
CapEx: -$173,735
Shares: 449,043
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $3.31
Stock Price: $3.31
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$6.85M
Net Income: -$6.85M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares BJDX against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 27, 2026 5:05am (3h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $249,040 | $0 | $0 | $0 |
| Cost of Revenue | $0 | $200,129 | $0 | $0 | $0 |
| Gross Profit | $0 | $48,911 | $0 | $0 | $0 |
| Operating Expenses | $3.2M | $9.4M | $10.3M | $7.2M | $7.0M |
| Operating Income | -$3.2M | -$9.3M | -$10.3M | -$7.2M | -$7.0M |
| Net Income | -$3.7M | -$9.3M | -$10.0M | -$7.7M | -$6.8M |
| EBITDA | -$3.0M | -$9.0M | -$9.2M | -$6.7M | -$6.7M |
| EPS | $-118.68 | $-292.88 | $-290.48 | $-456.76 | $-15.25 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 27, 2026 5:05am (3h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $19.0M | $10.1M | $2.2M | $4.3M | $5.2M |
| Total Current Assets | $20.7M | $11.8M | $3.2M | $4.9M | $5.5M |
| Total Assets | $21.0M | $13.5M | $4.9M | $6.7M | $7.1M |
| Current Liabilities | $637,162 | $1.6M | $1.8M | $810,368 | $1.1M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $637,162 | $2.0M | $2.0M | $927,924 | $1.1M |
| Total Equity | $20.4M | $11.5M | $2.9M | $5.7M | $6.0M |
| Retained Earnings | -$7.7M | -$17.0M | -$27.0M | -$34.7M | -$41.5M |
Cash Flow (Annual)
Last updated: Jun 27, 2026 5:05am (3h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$4.4M | -$7.7M | -$8.3M | -$7.8M | -$6.1M |
| Capital Expenditure | $-23,947 | -$1.2M | $-704,166 | $-306,783 | $-173,735 |
| Free Cash Flow | -$4.4M | -$8.9M | -$9.0M | -$8.1M | -$6.2M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $18.1M | -$8.9M | -$7.9M | $2.1M | $862,930 |
Analyst Estimates (Annual)
Last updated: Jun 26, 2026 9:11am (23h ago)| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Revenue |
$5.1M $5.1M – $5.1M
|
$7.9M $7.9M – $7.9M
|
$18.5M $18.5M – $18.5M
|
$32.7M $32.7M – $32.7M
|
| EBITDA |
$3.0M $3.0M – $3.0M
|
$4.7M $4.7M – $4.7M
|
$11.1M $11.1M – $11.1M
|
$19.6M $19.6M – $19.6M
|
| Net Income |
-$229.9M -$229.9M – -$229.9M
|
-$208.4M -$208.4M – -$208.4M
|
-$14.4M -$14.4M – -$14.4M
|
$179.6M $179.6M – $179.6M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 27, 2026 5:05am (3h ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | — | -100.0% | — | — |
| Gross Profit Growth | — | -100.0% | — | — |
| Operating Income Growth | -188.5% | -10.7% | +30.5% | +3.0% |
| Net Income Growth | -149.3% | -7.1% | +22.5% | +11.3% |
| EBITDA Growth | -202.2% | -2.0% | +27.0% | +0.3% |
Insider Trading (Recent)
Last updated: Jun 27, 2026 5:05am (3h ago)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-03-14 | Wurth Douglas Clark | P-Purchase | 12,500.00 | $2.00 | $25,000 |
| 2026-03-14 | Dey Indranil | P-Purchase | 12,500.00 | $2.00 | $25,000 |
| 2026-03-14 | CHASE DONALD R | P-Purchase | 12,500.00 | $2.00 | $25,000 |
| 2026-03-14 | ZEIDMAN FRED S | P-Purchase | 12,500.00 | $2.00 | $25,000 |
| 2026-03-14 | Dey Svetlana | P-Purchase | 12,500.00 | $2.00 | $25,000 |
| 2023-12-13 | Dey Svetlana | P-Purchase | 500.00 | $3.07 | $1,535 |
| 2023-12-13 | Dey Indranil | P-Purchase | 500.00 | $3.27 | $1,635 |
| 2023-09-26 | Scally Frances P | 0.00 | $0.00 | $0 | |
| 2023-03-24 | Dey Svetlana | P-Purchase | 10,000.00 | $0.44 | $4,400 |
| 2023-03-28 | Dey Indranil | P-Purchase | 2,000.00 | $0.44 | $880 |
| 2023-03-27 | Dey Indranil | P-Purchase | 8,000.00 | $0.44 | $3,520 |
| 2023-03-28 | Dey Indranil | A-Award | 2,000.00 | $0.44 | $880 |
| 2023-03-27 | Dey Indranil | A-Award | 8,000.00 | $0.44 | $3,520 |
| 2023-03-24 | Dey Svetlana | A-Award | 10,000.00 | $0.44 | $4,400 |
| 2023-03-07 | Cook Jason | 0.00 | $0.00 | $0 | |
| 2023-03-07 | Cook Jason | 0.00 | $0.00 | $0 | |
| 2023-03-07 | Cook Jason | 75,000.00 | $3.50 | $262,500 | |
| 2023-03-07 | Cook Jason | 5,324.00 | $1.09 | $5,803 | |
| 2023-02-01 | Gemignani Gary G | A-Award | 27,500.00 | $0.44 | $12,100 |
| 2023-02-01 | CHASE DONALD R | A-Award | 27,500.00 | $0.44 | $12,100 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for BJDX — it's generated by the pipeline (
market-narrative step).
No community reviews yet for BJDX.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30